Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)

Clinical Research Center for Dementia of South Korea (CREDOS)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01198093

Acronym

CREDOS

Enrollment

800

Registered

2010-09-09

Start date

2005-11-30

Completion date

2015-08-31

Last updated

2012-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Keywords

Alzheimer's disease, Mild Cognitive Impairment, cohort study

Brief summary

The objective of this study is to present evidence-based medicine for development of clinical practice guideline through prospective study of Alzheimer's disease(AD) and mild cognitive impairment(MCI) in korea

Detailed description

The specific aims of this study is (1) construction & maintenance of cohort for Alzheimer's disease(AD) and mild cognitive impairment(MCI); (2) study of epidemiology, rate of progression, risk factor, prognostic factor; (3) study of biomarker such as neuropsychological assessment, peripheral & CSF markers, neuroimaging(both structural & functional)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Alzheimer's disease(AD) and mild cognitive impairment(MCI)will be enrolled in the study. 1. the diagnostic criteria of Alzheimer's disease(AD) according to DSM IV or NINCDS -ADRDA 2. the diagnostic criteria of mild cognitive impairment(MCI) A. Memory or other cognitive complaint preferably corroborated by an informant B. Objective memory impairment or other cognitive for age and education C. Largely intact general cognitive function D. Essentially preserved ADL E. Not demented

Exclusion criteria

Countries

South Korea

Contacts

Primary ContactDoh K Kim, Ph.D

dohkwan.kim@samsung.com82-2-3410-3582

Outcome results